Welcome to LookChem.com Sign In|Join Free

CAS

  • or

91-19-0

Post Buying Request

91-19-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

91-19-0 Usage

Chemical Properties

light yellow to brown crystalline

Uses

Different sources of media describe the Uses of 91-19-0 differently. You can refer to the following data:
1. Organic synthesis.
2. Quinoxaline is a reagent used in the synthesis of quinoxaline diimides as small molecule non-fullerene acceptors for organic solar cells.

Definition

ChEBI: A naphthyridine in which the nitrogens are at positions 1 and 4.

Synthesis Reference(s)

Journal of the American Chemical Society, 69, p. 795, 1947 DOI: 10.1021/ja01196a015The Journal of Organic Chemistry, 55, p. 1744, 1990 DOI: 10.1021/jo00293a014Organic Syntheses, Coll. Vol. 4, p. 824, 1963

General Description

Transition metal-free acylation of quinoxaline derivatives, by cross dehydrogenative coupling (CDC) reaction, were studied.

Purification Methods

Crystallise quinoxaline from pet ether. It crystallises as the monohydrate on addition of water to a pet ether solution. It has UV: at 242 and 331nm (Ho –2); 234 and 316nm (pH 7.1). The picrate has m 161-162o.[Albert & Phillips J Chem Soc 1294 1956, Beilstein 23 H 176, 23 II 177, 23 III/IV 1226, 23/7 V 135.]

Check Digit Verification of cas no

The CAS Registry Mumber 91-19-0 includes 5 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 2 digits, 9 and 1 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 91-19:
(4*9)+(3*1)+(2*1)+(1*9)=50
50 % 10 = 0
So 91-19-0 is a valid CAS Registry Number.

91-19-0 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A14055)  Quinoxaline, 98+%   

  • 91-19-0

  • 25g

  • 199.0CNY

  • Detail
  • Alfa Aesar

  • (A14055)  Quinoxaline, 98+%   

  • 91-19-0

  • 100g

  • 720.0CNY

  • Detail
  • Alfa Aesar

  • (A14055)  Quinoxaline, 98+%   

  • 91-19-0

  • 500g

  • 3132.0CNY

  • Detail
  • Alfa Aesar

  • (A14055)  Quinoxaline, 98+%   

  • 91-19-0

  • 2500g

  • 13370.0CNY

  • Detail
  • Sigma-Aldrich

  • (49498)  Quinoxaline  analytical standard

  • 91-19-0

  • 49498-100MG

  • 499.59CNY

  • Detail
  • Aldrich

  • (22710)  Quinoxaline  ≥95.0%

  • 91-19-0

  • 22710-100G-F

  • 552.24CNY

  • Detail
  • Aldrich

  • (Q1603)  Quinoxaline  99%

  • 91-19-0

  • Q1603-25G

  • 331.11CNY

  • Detail

91-19-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name quinoxaline

1.2 Other means of identification

Product number -
Other names Quinoxaline

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:91-19-0 SDS

91-19-0Relevant articles and documents

Synthesis of Diverse Functionalized Quinoxalines by Oxidative Tandem Dual C?H Amination of Tetrahydroquinoxalines with Amines

Zhao, He,Li, Xiu,Guan, Rongqing,Jiang, Huanfeng,Zhang, Min

, p. 15858 - 15862 (2019)

The tandem dual C?H amination of tetrahydroquinoxalines with free amines under aerobic copper catalysis conditions has been demonstrated. The synthetic protocol proceeds with good substrate and functional group compatibility, mild reaction conditions, short reaction time, the use of the naturally abundant [Cu]/O2 catalyst system, excellent chemoselectivity and synthetic efficiency, and with no need for the pre-installation of specific aminating agents, which offers a practical platform for the rapid and diverse synthesis of diaminoquinoxalines. Moreover, this work has shown the potential of single-electron-oxidation-induced C?H functionalization of N-heterocycles, and its application in the development of optoelectronic materials.

Mechanism of Cyclisation of Aryliminoiminyl Radicals

McNab, Hamish

, p. 422 - 423 (1980)

The title radicals (5) and (8) cyclise to mixtures of quinoxalines (6) and (9), via competing pathways which involve ipso or ortho attack on the aryl ring.

Method for realizing oxidative dehydrogenation of nitrogen-containing heterocyclic ring by using biomass-based carbon material

-

Paragraph 0010-0011; 0034-0035, (2021/06/26)

The invention provides a method for realizing oxidative dehydrogenation of a nitrogen-containing heterocyclic ring by using a biomass-based carbon material, and belongs to the field of organic synthesis. According to the method, the raw materials of the biomass-based carbon material comprise wheat, sorghum, rice, corn straw, wheat straw, peanut shells, sesame shells, bean shells and the like, and are crushed and then ground into powder, the powder is fully mixed with an inorganic alkali, and calcination is performed in an inert gas atmosphere to prepare the biomass-based carbon material; and by using air as an oxygen source, at a temperature of 50-120 DEG C, oxidative dehydrogenation of nitrogen-containing heterocyclic compounds to synthesize quinoline compounds, isoquinoline compounds, acridine compounds, quinazoline compounds, indole compounds, imine compounds, and even quinoline compounds with pharmaceutical activity can be achieved. According to the present invention, easily available wheat flour is adopted as a raw material to prepare a non-metal catalyst, the alkali is not added during the reaction process, and a remarkable industrial application prospect is achieved.

Monomeric vanadium oxide: A very efficient species for promoting aerobic oxidative dehydrogenation of N-heterocycles

Xie, Zhenbing,Chen, Bingfeng,Zheng, Lirong,Peng, Fangfang,Liu, Huizhen,Han, Buxing

, p. 431 - 437 (2021/01/11)

Monomeric active species are very interesting in heterogeneous catalysis. In this work, we proposed a method to prepare VOx-NbOy@C catalysts, which involve the one-pot hydrothermal synthesis of inorganic/organic hybrid materials containing V/Nb followed by thermal treatment under a reducing atmosphere. The prepared catalysts were characterized using different techniques, such as high-angle annular dark-field scanning transmission electron microscopy and X-ray absorption fine structure spectroscopy. It was shown that monomeric VOx species were dispersed homogeneously in the catalysts. The VOx-NbOy@C catalysts displayed high performance in the aerobic oxidative dehydrogenation of N-heterocycles to aromatic heterocycles. It was demonstrated that the selectivity of reaction over the catalyst with a very small amount of V (0.07 wt%) was much higher than that over the NbOy@C, and the catalyst also exhibited excellent stability in the reaction. The detailed study indicated that monomeric VO2 species were the most effective for promoting the reaction. This journal is

Synthesis, biological evaluation, and in silico studies of new acetylcholinesterase inhibitors based on quinoxaline scaffold

Khongkow, Pasarat,Lomlim, Luelak,Nualnoi, Teerapat,Saetang, Jirakrit,Suwanhom, Paptawan,Tipmanee, Varomyalin

, (2021/08/20)

A quinoxaline scaffold exhibits various bioactivities in pharmacotherapeutic interests. In this research, twelve quinoxaline derivatives were synthesized and evaluated as new acetyl-cholinesterase inhibitors. We found all compounds showed potent inhibitory activity against acetyl-cholinesterase (AChE) with IC50 values of 0.077 to 50.080 μM, along with promising predicted drug-likeness and blood–brain barrier (BBB) permeation. In addition, potent butyrylcholinesterase (BChE) inhibitory activity with IC50 values of 14.91 to 60.95 μM was observed in some compounds. Enzyme kinetic study revealed the most potent compound (6c) as a mixed-type AChE inhibitor. No cytotoxicity from the quinoxaline derivatives was noticed in the human neuroblastoma cell line (SHSY5Y). In silico study suggested the compounds preferred the peripheral anionic site (PAS) to the catalytic anionic site (CAS), which was different from AChE inhibitors (tacrine and galanthamine). We had proposed the molecular design guided for quinoxaline derivatives targeting the PAS site. Therefore, the quinoxaline derivatives could offer the lead for the newly developed candidate as potential acetylcholinesterase inhibitors.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 91-19-0